Tian Zhu is the CEO and Co-Founder of GenEditBio, a biotechnology company focused on in vivo CRISPR-Cas ribonucleoprotein-based genome editing therapies.
Tian Zhu is the CEO and Co-Founder of GenEditBio, a biotechnology company focused on in vivo CRISPR-Cas ribonucleoprotein-based genome editing therapies. He has held this role since January 2022. Under his leadership, GenEditBio has received FDA clearance for its IND application and dosed its first patient in an investigator-initiated trial.
Full founder directory · Investor directory · Company funding database · Fundraising library